US › Healthcare

The Joint Corp (JYNT)

US · Healthcare · Medical Care Facilities

$8.28+0.85%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$14.8M
Revenue YoY
+13.3%
Net profit
$1.3M
Profit YoY
+34.2%
EPS
$0.08
EPS estimate
$0.03
Net margin
8.8%

EPS came in at 0.08 against a street estimate of 0.03 — a beat of 166.7%.

Key statistics

Market cap
$118.2M
P/E
92.1
Forward P/E
14.1
P/B
7.66
Book value
$1.13
EPS (TTM)
$0.09
52-week high
$11.26
52-week low
$7.50
50-day MA
$8.83
200-day MA
$8.80
Beta
1.09

Analyst view

Analysts rate The Joint Corp a buy (3 buy, 2 hold, 0 sell out of 5) with an average price target of $10.00.

Shareholding

Insiders
16.10%
Institutions
73.38%

Largest institutional holders

FundStake
Bandera Partners LLC27.62%
Skylands Capital, LLC6.28%
BlackRock Inc5.29%
Vanguard Capital Management, LLC4.18%
JCP Investment Management, LLC4.17%
Keller Group Invmt Management Inc2.37%
Geode Capital Management, LLC2.02%
State Street Corp2.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for The Joint Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.